Skip to main content
. 2015 Apr 8;5:9465. doi: 10.1038/srep09465

Figure 1. RCC cells with mutated VHL or SETD2 were sensitive to TGX221, reproduced from the Genomics of Drug Sensitivity in Cancer (GDSC) database.

Figure 1

Volcano plotting showing compounds marked in green as sensitive in the setting of RCC cells with (A) VHL gene and (B) SETD2 gene mutations, with TGX221 present in both settings. Scattered plotting showing cells with VHL (C) or SETD2 (D) mutations were all RCC cells. (*P <0.05; **P <0.01)